Contact this trialFirst, we need to learn more about you.
Chemotherapy
TNO155 + Spartalizumab/Ribociclib for Cancer
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial is testing a new drug, TNO155, in combination with two other drugs, spartalizumab or ribociclib, to see if it is safe and effective in treating advanced solid tumors. The study will enroll subjects in two groups to compare the safety, tolerability, and preliminary effectiveness of the two combinations. Treatment will continue until the subject experiences unacceptable toxicity, disease progression, or treatment is discontinued at the discretion of the Investigator or the subject, or the subject withdraws consent.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.